Loading
HKSEHealthcareBiotechnology
Latest quote
HK$2.85
+HK$0.015 · +0.53%
Shandong Boan Biotechnology Co., Ltd. is a biopharmaceutical company, which engages in therapeutic antibody development, manufacturing and commercialization. It operates through the Mainland China and Other countries geographical segments. It focuses on key therapeutic areas including oncology, metabolism, autoimmunity, and ophthalmology. The company was founded on December 30, 2013 and is headquartered in Yantai, China.
Latest quote
HK$2.85
+HK$0.015 · +0.53%
Regular session · HKT · Market data may be delayed.
Shandong Boan Biotechnology Co., Ltd. is a biopharmaceutical company, which engages in therapeutic antibody development, manufacturing and commercialization. It operates through the Mainland China and Other countries geographical segments. It focuses on key therapeutic areas including oncology, metabolism, autoimmunity, and ophthalmology. The company was founded on December 30, 2013 and is headquartered in Yantai, China.
Day range
Current HK$2.85
52-week range
Current HK$2.85
Regular session · HKT · Market data may be delayed.
Shandong Boan Biotechnology Co., Ltd. is a biopharmaceutical company, which engages in therapeutic antibody development, manufacturing and commercialization. It operates through the Mainland China and Other countries geographical segments. It focuses on key therapeutic areas including oncology, metabolism, autoimmunity, and ophthalmology. The company was founded on December 30, 2013 and is headquartered in Yantai, China.
Day range
Current HK$2.85
52-week range
Current HK$2.85
Recent quarterly results
Recent quarterly results
Funds reporting this stock among their holdings, ordered by reported position size.
State Street SPDR Portfolio Emerging Markets ETFSPEM219.56K0.00%17.86B USD0.07%$52.51+0.67%
State Street SPDR S&P Emerging Markets Small Cap ETFEWX63.63K0.01%684.6M USD0.65%$72.61+0.30%
State Street SPDR S&P China ETFGXC10.48K0.00%469.71M USD0.59%$87.58-0.21%
Dimensional - Emerging Markets Core Equity 2 ETFDFEM3.54K0.00%9.62B USD0.39%$40.53+1.12%
Avantis Emerging Markets Small Cap Equity ETFAVEE2.66K—141.01M USD0.42%$69.08+0.73%
iShares LifePath Target Date 2050 ETFITDF70.230.00%95.1M USD0.11%$42.065+0.80%State Street SPDR Portfolio Emerging Markets ETFSPEMState Street SPDR S&P Emerging Markets Small Cap ETFEWXState Street SPDR S&P China ETFGXCDimensional - Emerging Markets Core Equity 2 ETFDFEMAvantis Emerging Markets Small Cap Equity ETFAVEEiShares LifePath Target Date 2050 ETFITDFAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
